Changes in 2-fluoro-2-deoxy-D-glucose incorporation, hexokinase activity and lactate production by breast cancer cells responding to treatment with the anti-HER-2 antibody trastuzumab

Cheyne, Richard, W.Trembleau, Laurent Alain ClaudeMcLaughlin, AbbieSmith, Timothy Andrew Davies2011-08-112011-08-112011-04Cheyne, R W, Trembleau, L A C, McLaughlin, A & Smith, T A D 2011, 'Changes in 2-fluoro-2-deoxy-D-glucose incorporation, hexokinase activity and lactate production by breast cancer cells responding to treatment with the anti-HER-2 antibody trastuzumab', Nuclear Medicine and Biology, vol. 38, no. 3, pp. 339-346. https://doi.org/10.1016/j.nucmedbio.2010.09.0050969-8051ORCID: /0000-0001-6376-9077/work/72631846ORCID: /0000-0001-9960-723X/work/45087521http://hdl.handle.net/2164/20998669875engSDG 3 - Good Health and Well-beingTrastuzumabFDGPETHexokinaseLactateR MedicineRChanges in 2-fluoro-2-deoxy-D-glucose incorporation, hexokinase activity and lactate production by breast cancer cells responding to treatment with the anti-HER-2 antibody trastuzumabJournal article10.1016/j.nucmedbio.2010.09.005383